Migraine Pain Relief
Most have fast migraine pain relief within 2 hours.**60% of people had migraine pain relief within 2 hours.
UBRELVY is proven to treat migraine attacks
Most have fast migraine pain relief within 2 hours.**60% of people had migraine pain relief within 2 hours.
The most common side effects were nausea (2-4%) and sleepiness (2-3%).
UBRELVY is an oral, non-narcotic medication taken at the onset of a migraine attack. As a member of a new class of acute treatments for migraine attacks, it is the first medication specifically designed and approved to treat attacks as they occur. It works by directly blocking the receptor for a protein called CGRP, which is believed to trigger pain and inflammation during migraine attacks.
CGRP is released, binding to receptors and triggering pain and inflammation.
UBRELVY blocks CGRP from binding to the receptors.
By blocking the receptors, UBRELVY acts at a major source of inflammation and pain during a migraine attack.
UBRELVY can be taken at the early signs of a migraine attack—before head pain starts.
Convenient access to treatment wherever you go with On-the-Go Packs.
Two dosage strengths available that can be taken anytime, anywhere.† If needed, a second dose can be taken 2 hours after the first.†People took UBRELVY within 4 hours of a migraine attack.
Get more per month with UBRELVY 100 mg 16-count pill packs, so you can treat migraine attacks when you need to. Ask your healthcare provider if the 16-count pill pack is right for you.
Safety of UBRELVY for more than 8 migraine attacks in 30 days is unknown.
including those that happen around the time of your period.
60%
have them during their period.‡ UBRELVY can help treat migraine attacks, including the ones that can happen during your period.
‡Loder EW. Headache 2006;46(Suppl 2):S55-60.
That is, before or during your period. Some people get migraine attacks at other times of the month as well.
CAT
Real UBRELVY patient
hear more storiesDo not take UBRELVY if you are taking medicines known as strong CYP3A4 inhibitors, such as ketoconazole, clarithromycin, or itraconazole, or if you are allergic to UBRELVY or any of its ingredients.
Before taking UBRELVY, tell your healthcare provider about all your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Your healthcare provider can tell you if it is safe to take UBRELVY with other medicines.
UBRELVY may cause serious side effects, including:
The most common side effects of UBRELVY are nausea (4%) and sleepiness (3%). These are not all of the possible side effects of UBRELVY.
UBRELVY is a prescription medicine used for the acute treatment of migraine attacks with or without aura in adults. UBRELVY is not used to prevent migraine headaches.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.
US-UBR-250100
Please see full Patient Information.